ID

16834

Descrição

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00184613

Link

https://clinicaltrials.gov/show/NCT00184613

Palavras-chave

  1. 09/08/2016 09/08/2016 -
Transferido a

9 de agosto de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Diabetes NCT00184613

Eligibility Diabetes NCT00184613

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00184613
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with type 2 diabetes for more than 2 years
Descrição

Type 2 diabetes

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0011860
subjects currently treated with unchanged insulin glargine dose (10 -100 units) for 2 weeks
Descrição

insulin glargine

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0907402
subjects currently treated with unchanged dose(s) for at least 1 month on one or two oral anti-diabetic drugs
Descrição

oral anti-diabetic drugs

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0359086
bmi 25 - 40 kg/m2
Descrição

BMI

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1305855
hba1c < 9.5 %
Descrição

HbA1C

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0202054
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to trial product(s) or related products
Descrição

allergy to trial product(s) or related products

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0907402
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0123677
previous randomisation in this trial
Descrição

previous randomisation in this trial

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348568
pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures (only sterilisation, intra uterine devices and contraceptive pills are considered adequate contraceptive methods)
Descrição

pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C2081645
UMLS CUI [4]
C0700589
mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation.
Descrição

mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
any other significant illness such as endocrine, cardiac, neurological, malignant or other pancreatic illness judged by investigator
Descrição

other significant illness

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009488
participation in other studies within the last three months
Descrição

participation in other studies

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Diabetes NCT00184613

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00184613
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes
Item
subjects with type 2 diabetes for more than 2 years
boolean
C0011860 (UMLS CUI [1])
insulin glargine
Item
subjects currently treated with unchanged insulin glargine dose (10 -100 units) for 2 weeks
boolean
C0907402 (UMLS CUI [1])
oral anti-diabetic drugs
Item
subjects currently treated with unchanged dose(s) for at least 1 month on one or two oral anti-diabetic drugs
boolean
C0359086 (UMLS CUI [1])
BMI
Item
bmi 25 - 40 kg/m2
boolean
C1305855 (UMLS CUI [1])
HbA1C
Item
hba1c < 9.5 %
boolean
C0202054 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
allergy to trial product(s) or related products
Item
known or suspected allergy to trial product(s) or related products
boolean
C0020517 (UMLS CUI [1,1])
C0907402 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0123677 (UMLS CUI [2,2])
previous randomisation in this trial
Item
previous randomisation in this trial
boolean
C2348568 (UMLS CUI [1])
pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures
Item
pregnancy, breast-feeding, intention of becoming pregnant or pre-menopausal women judged not to be using adequate contraceptive measures (only sterilisation, intra uterine devices and contraceptive pills are considered adequate contraceptive methods)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C2081645 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation
Item
mental incapacity, unwillingness or language barriers precluding adequate understanding and co-operation.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
other significant illness
Item
any other significant illness such as endocrine, cardiac, neurological, malignant or other pancreatic illness judged by investigator
boolean
C0009488 (UMLS CUI [1])
participation in other studies
Item
participation in other studies within the last three months
boolean
C2348568 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial